{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-037226","form_type":"8-K/A","ticker":"LSTA","cik":"0000320017","company_name":"LISATA THERAPEUTICS, INC.","filed_at":"2022-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.154311+00:00","generated_at":"2026-06-23T03:40:46.794722+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Lisata files audited FY2020-2021 financials of acquired Cend Therapeutics","bullets":["Audited financial statements of Cend for FY2020 and FY2021 filed as Exhibit 99.1.","Consent of independent auditor WithumSmith+Brown, PC filed as Exhibit 23.1.","This amendment fulfills the remaining financial statement requirements for the September 2022 merger.","No other changes were made to the initial Form 8-K reporting the merger completion."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-037226","json":"https://secwatch.observer/filing/0001140361-22-037226.json","markdown":"https://secwatch.observer/filing/0001140361-22-037226.md","text":"https://secwatch.observer/filing/0001140361-22-037226.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320017/000114036122037226/0001140361-22-037226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320017/000114036122037226/brhc10042873_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T03:40:46.794722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}